Cell MedX Corp.

CMXC · OTC
Analyze with AI
8/31/2025
5/31/2025
2/28/2025
11/30/2024
Operating Activities
Net Income-$266-$205-$155-$140
Dep. & Amort.$0$0$0$0
Deferred Tax$0$0$0$0
Stock-Based Comp.$0$0$0$0
Change in WC$0$13-$128$64
Other Non-Cash$157$119$253$59
Operating Cash Flow-$108-$72-$30-$17
Investing Activities
PP&E Inv.$0-$0$0$0
Net Acquisitions$0$0$0$0
Inv. Purchases$0$0$0$0
Inv. Sales/Matur.$0$0$0$0
Other Inv. Act.$0$0$0$0
Investing Cash Flow$0-$0$0$0
Financing Activities
Debt Repay.$0$0$0$0
Stock Issued$0-$1$1$0
Stock Repurch.$0$0$0$0
Dividends Paid$0$0$0$0
Other Fin. Act.$100$31$52$30
Financing Cash Flow$100$31$52$30
Forex Effect$0$0-$0-$0
Net Chg. in Cash-$8$8-$14$13
Supplemental Information
Beg. Cash$15$7$21$21
End Cash$6$15$7$34
Free Cash Flow-$108-$72-$30-$17
Cell MedX Corp. (CMXC) Financial Statements & Key Stats | AlphaPilot